Sugi Predict

Sugi Predict / Compounds / SCHEMBL1034072

SCHEMBL1034072

SCHEMBL1034072

O=C(Nc1ccncc1)c1cccc2ccc(-c3cccc(C(F)(F)F)c3)nc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.51
▸ JAK1 P23458 1/20 0.51
▸ TYK2 P29597 1/20 0.51
▸ RXFP1 Q9HBX9 4/20 0.50
▸ EGLN1 Q9GZT9 1/20 0.49
▸ EGFR P00533 2/20 0.48
▸ KDR P35968 2/20 0.48
▸ ABL1 P00519 1/20 0.48
▸ CSF1R P07333 1/20 0.48
▸ PDGFRB P09619 1/20 0.48
▸ KIT P10721 1/20 0.48
▸ FLT1 P17948 1/20 0.48
▸ FLT4 P35916 1/20 0.48
▸ SIRT2 Q8IXJ6 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ CA12 O43570 2/20 0.47
▸ CA1 P00915 2/20 0.47
▸ CA2 P00918 2/20 0.47
▸ CA9 Q16790 2/20 0.47
▸ IDE P14735 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1034065 0.91 RXFP1 (0.53) RXFP1CA12CA1CA2CA9
SCHEMBL1032356 0.89 CSF1R (0.54) RXFP1EGLN1KDRABL1CSF1R
SCHEMBL1033800 0.87 KMO (0.47) RXFP1EGLN1KDRPDGFRBKIT
SCHEMBL1034305 0.86 KMO (0.49) RXFP1EGLN1SIRT2ALDH1A1CA12
SCHEMBL1035234 0.86 MPL (0.52) RXFP1EGLN1MAPTKMONPSR1
SCHEMBL1032167 0.85 MEN1 (0.48) KDRABL1SIRT2ALDH1A1MAPT
SCHEMBL1035430 0.85 ELANE (0.55) EGFRKDRABL1CSF1RPDGFRB
SCHEMBL1034603 0.84 ALOX15 (0.59) RXFP1KDRFLT4SIRT2FGFR1
SCHEMBL1033871 0.83 FGFR4 (0.51) RXFP1EGLN1SIRT2ALDH1A1MAPT
SCHEMBL1034242 0.83 ALDH1A1 (0.54) JAK2TYK2EGLN1EGFRABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2273992-B1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2016-05-25 — — EP disclosed
EP-2273992-B1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC (US) 2016-05-25 — — EP disclosed
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2011-02-24 — — US disclosed
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2011-02-24 — — US disclosed
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE LLC 2011-02-24 — — US disclosed
EP-2273992-A1 QUENOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS Sirtris Pharmaceuticals, Inc. (US) 2011-01-19 — — EP disclosed
WO-2009134973-A1 QUENOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2009-11-05 — — WO disclosed
WO-2009134973-A1 QUENOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. (US) 2009-11-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046110-A1 QUINOLINES AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRT3, SIRT1, SIRT2 JAK2 1125/4885JAK1 2618/4885TYK2 1013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.